glen allen, virginia, May 7, 2024 /CNW/ — Remidio Inc., a medical technology innovator developing cutting-edge technologies to combat global blindness due to diabetic retinopathy, glaucoma, AMD and cataracts, is on track to achieve a major milestone. I am.
This quarter, Remidio Inc. is excited to hit 1,000.th The FOP-NM handheld fundus camera is available to healthcare providers in the United States. Since 2019, these devices have supported the diabetic retinopathy screening efforts of more than 3,500 high-volume healthcare providers in the United States.
Remidio's FOP-NM is the world's first smartphone-based, non-mydriatic fundus camera that eliminates the need for patient dilation and is rapidly revolutionizing retinal examinations in the United States. It has an equal impact within the clinic and outside of it.
The FOP-NM is an easy-to-use, easy-to-train retinal camera that provides excellent image quality and can be used by medical professionals and non-professionals (nurses, other health care workers) in the clinic, at home, in the emergency room, etc. Enables retinal examinations to be performed anywhere. or a remote rural medical center.
The device's portability has also been widely accepted by academic health systems. University of Virginiaand a few others.
University of Virginia Assistant Professor of Ophthalmology, Dr. Arjun Dilgangi “Remidio's FOP-NM is easy to use and easy to train. Even trainees who have never used the system before have been able to obtain good images within 30 seconds to 2 minutes per eye. My goals “At the end of the day, it's about improving access to testing, and this is certainly one of the more powerful tools I've seen to do that.”
Many handheld fundus cameras tout “superior image quality,” but Remidio's FOP-NM stands out. In a comparative clinical validation study published in Nature Eye, Remidio's FOP-NM provided image quality comparable to the “imaging gold standard.”
FOP-NM's clinically validated technology, along with its ease of use, results in a workflow for screening retinal conditions that makes image acquisition easy, even for beginners.
Chief Commercial Officer of Remidio; Eric Hufkeyfurther adds, “Our goal is to impact the lives of almost everyone.” 30M There is a risk of diabetic retinopathy in the United States. Achieving this goal will require new partnerships with proven technologies. Remidio is pleased to make its hardware and telemedicine platform publicly available for collaboration with AI SaMD companies and healthcare providers working to bring care closer to patients. Our vision of using retinal imaging to see “windows into the body” does not end with eye diseases. We are looking for many other chronic diseases that may be detected early using retinal imaging. The Remidio device's portability, affordability, and ease of use make it a natural fit into existing clinical workflows, allowing this technology to rapidly scale its impact. ”
As Remidio continues to break new ground with technology and collaboration, Remidio's team of more than 170 people is committed to delivering healthier vision in a world where advanced technologies and their users come together to ensure eye health for all. We remain dedicated to one vision: Building tomorrow. One vision at a time makes a difference in the lives of millions of people.
Remidio is an innovative ISO 13485 certified medical device company that aims to impact preventable blindness by developing smart, easy-to-use and accessible technology. Remidio's CE Mark and FDA 510k Registered medical devices have helped screen and impact more than 15 million patients in more than 40 countries around the world.
Media contact: Eric Hufkey
chief commercial officer
erik@remidio.com
+1 – 888-627-1416
Photo: https://mma.prnewswire.com/media/2405447/Remidio_s_FOP_NM.jpg
Logo: https://mma.prnewswire.com/media/2405840/Remidio_Innovative_Solutions_Logo.jpg
View original content to download multimedia: https://www.prnewswire.com/news-releases/health-tech-innovator-remidio-achieves-unprecedented-scale-in-the-us- with-its-revolutionary-retinal-solutions -302137533.html
SOURCE Remidio's innovative solution
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2024/06/c0561.html
